drugset / Trial / NCT01341912

Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

NCT01341912

Phase 3 Completed 3 enrolled Octapharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to study the long-term efficacy, safety and tolerability of Human-cl rhFVIII in previously treated patients with severe hemophilia A.

Timeline

Start
2011-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject simoctocog alfa Protein / enzyme biologic Intravenous

Indications